The discounted acquisition of a once-promising biotech development site signals just how far Emeryville's life sciences market has cratered. A San Francisco real estate investor has scooped up a 128,000-square-foot Emeryville property at roughly half its previous sale price, in a transaction that crystallizes the collapse of the East Bay life sciences market that, just […]
Thank you for your interest in The Registry. If you'd like to read further, you must Subscribe or Log In below to read the rest of this content.
Signup for news and special announcements!
You have successfully joined our subscriber list.
Swinerton has moved its San Francisco division out of 260 Townsend Street...
ByThe RegistryNovember 9, 2026An investment-grade dialysis operator's roughly $10 million bet on a former South...
ByThe RegistryNovember 9, 2026Texas is booming, with new retail, data centers and people. But the...
ByThe RegistryNovember 9, 2026San Francisco planners signed off on Align Real Estate's plan to replace...
ByThe RegistryNovember 9, 2026